DocGo

Aging Demographics Will Drive Mobile Care Amid Challenges

AnalystHighTarget

Not Invested

Community Contributor

Published

17 May 25

AnalystHighTarget's Fair Value

US$4.00

68.3% undervalued

10 Sep

US$1.27

-59.6%

-6.6%

-59.6%

-6.6%

You can edit this narrative until May 17 9:17 PM. Then, changes will post as Updates.

Author's Valuation

US$468.3% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$4

68.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

-11.61%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.80%

Calculation

US$17.92m

Earnings '28

23.38x

PE Ratio '28

US$418.85m

Market Cap '28

US$418.85m

Market Cap '28

86.11m

No. shares '28

US$4.86

Share Price '28

US$4.86 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$4.00

Fair Value '25